Steroid sulfatase inhibiting lanostane triterpenes - Structure activity relationship and in silico insights

被引:11
作者
Grienke, Ulrike [1 ]
Kaserer, Teresa [2 ,3 ]
Kirchweger, Benjamin [1 ]
Lambrinidis, George [4 ]
Kandel, Ralph T. [2 ,3 ]
Foster, Paul A. [5 ,6 ]
Schuster, Daniela [2 ,3 ,7 ]
Mikros, Emmanuel [1 ,4 ]
Rollinger, Judith M. [1 ]
机构
[1] Univ Vienna, Fac Life Sci, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria
[2] Univ Innsbruck, Inst Pharm Pharmaceut Chem, Innrain 80-82, A-6020 Innsbruck, Austria
[3] Univ Innsbruck, Ctr Mol Biosci Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria
[4] Natl & Kapodistrian Univ Athens, Panepistimiopolis Zografou, Sch Hlth Sci, Dept Pharm,Div Pharmaceut Chem, Athens 15771, Greece
[5] Univ Birmingham, Inst Metab & Syst Res, Birmingham B15 2TJ, W Midlands, England
[6] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England
[7] Paracelsus Med Univ Salzburg, Dept Pharmaceut & Med Chem, Inst Pharm, Salzburg, Austria
关键词
Steroid sulfatase; Polypores; Lanostane-type triterpenes; Virtual screening; Molecular docking; POTENT INHIBITORS; REVERSIBLE INHIBITORS; ESTRONE SULFATASE; IROSUSTAT; PROTEIN; PHARMACOPHORE; DISCOVERY;
D O I
10.1016/j.bioorg.2019.103495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroid sulfatase (STS) transforms hormone precursors into active steroids. Thus, it represents a target of intense research regarding hormone-dependent cancers. In this study, three ligand-based pharmacophore models were developed to identify STS inhibitors from natural sources. In a pharmacophore-based virtual screening of a curated molecular TCM database, lanostane-type triterpenes (LTTs) were predicted as STS ligands. Three traditionally used polypores rich in LTTs, i.e., Ganoderma lucidum Karst., Gloeophyllum odoratum Imazeki, and Fomitopsis pinicola Karst., were selected as starting materials. Based on eighteen thereof isolated LTTs a structure activity relationship for this compound class was established with piptolinic acid D (1), pinicolic acid B (2), and ganoderol A (3) being the most pronounced and first natural product STS inhibitors with IC50 values between 10 and 16 mu M. Molecular docking studies proposed crucial ligand target interactions and a prediction tool for these natural compounds correlating with experimental findings.
引用
收藏
页数:10
相关论文
共 44 条
  • [1] [Anonymous], [No title captured]
  • [2] [Anonymous], [No title captured]
  • [3] Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment
    Barbieri, Antonio
    Quagliariello, Vincenzo
    Del Vecchio, Vitale
    Falco, Michela
    Luciano, Antonio
    Amruthraj, Nagoth Joseph
    Nasti, Guglielmo
    Ottaiano, Alessandro
    Berretta, Massimiliano
    Iaffaioli, Rosario Vincenzo
    Arra, Claudio
    [J]. NUTRIENTS, 2017, 9 (03):
  • [4] Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review
    Begam, A. Jameera
    Jubie, S.
    Nanjan, M. J.
    [J]. BIOORGANIC CHEMISTRY, 2017, 71 : 257 - 274
  • [5] TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
    Chen, Calvin Yu-Chian
    [J]. PLOS ONE, 2011, 6 (01):
  • [6] Characterization of the Chemical Space of Known and Readily Obtainable Natural Products
    Chen, Ya
    de Lomana, Marina Garcia
    Friedrich, Nils-Ole
    Kirchmair, Johannes
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2018, 58 (08) : 1518 - 1532
  • [7] A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
    Coombes, R. Charles
    Cardoso, Fatima
    Isambert, Nicolas
    Lesimple, Thierry
    Soulie, Patrick
    Peraire, Concepcion
    Fohanno, Veronique
    Kornowski, Anne
    Ali, Tauhid
    Schmid, Peter
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 73 - 82
  • [8] Structure Based Design, Synthesis, and Evaluation of Potential Inhibitors of Steroid Sulfatase
    Costa, E. V.
    Sousa, E.
    Choosang, K.
    Singh, S.
    Rocha, J.
    Lima, R. T.
    Pakkong, P.
    Ahmed, S.
    Vasconcelos, M. H.
    Montanari, C. A.
    Pinto, M. M.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (08) : 1033 - 1044
  • [9] Human sulfatases: A structural perspective to catalysis
    Ghosh, D.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (15) : 2013 - 2022
  • [10] 1H NMR-MS-based heterocovariance as a drug discovery tool for fishing bioactive compounds out of a complex mixture of structural analogues
    Grienke, Ulrike
    Foster, Paul A.
    Zwirchmayr, Julia
    Tahir, Ammar
    Rollinger, Judith M.
    Mikros, Emmanuel
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1) : 11113